Literature DB >> 15974869

Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.

P J Mason1, D B Wilson, M Bessler.   

Abstract

Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome associated with abnormalities of the skin, fingernails, and tongue. Other clinical manifestations may include epiphora, lung fibrosis, liver cirrhosis, osteoporosis, and a predisposition to develop a variety of malignancies. The clinical picture often resembles that of a premature aging syndrome and tissues affected are those with a high cell turnover. DC has been linked to mutations in at least four distinct genes, three of which have been identified. The product of these genes, dyskerin, the telomerase RNA (TERC), and the catalytic unit of telomerase (TERT) are part of a ribonucleoprotein complex, the telomerase enzyme, that is essential for the elongation and maintenance of chromosome ends or telomeres. All patients with DC have excessively short telomeres, indicating that the underlying defect in these individuals is an inability to maintain the telomeres. The purpose of the current review is to highlight recent insights into the molecular pathogenesis of DC. We discuss the impact these findings have on our current understanding of telomere function and maintenance, and on the diagnosis, management, and treatment of patients with conditions caused by dysfunctional telomeres.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974869     DOI: 10.2174/1566524053586581

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  46 in total

1.  The Nobel Prize in physiology or medicine 2009 "for telomere biology" and its relevance to cancer and related diseases.

Authors:  Rosario Perona
Journal:  Clin Transl Oncol       Date:  2010-10       Impact factor: 3.405

Review 2.  The biogenesis and regulation of telomerase holoenzymes.

Authors:  Kathleen Collins
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

3.  CTC1 Mutations in a patient with dyskeratosis congenita.

Authors:  Rachel B Keller; Katelyn E Gagne; G Naheed Usmani; George K Asdourian; David A Williams; Inga Hofmann; Suneet Agarwal
Journal:  Pediatr Blood Cancer       Date:  2012-04-24       Impact factor: 3.167

4.  High-throughput telomere length quantification by FISH and its application to human population studies.

Authors:  Andrés Canela; Elsa Vera; Peter Klatt; María A Blasco
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

Review 5.  Cellular lifespan and regenerative medicine.

Authors:  Thomas Petersen; Laura Niklason
Journal:  Biomaterials       Date:  2007-05-25       Impact factor: 12.479

6.  The longest telomeres: a general signature of adult stem cell compartments.

Authors:  Ignacio Flores; Andres Canela; Elsa Vera; Agueda Tejera; George Cotsarelis; María A Blasco
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

Review 7.  Emerging concepts in the pathogenesis of lung fibrosis.

Authors:  William D Hardie; Stephan W Glasser; James S Hagood
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

8.  DKC1 overexpression associated with prostate cancer progression.

Authors:  P Sieron; C Hader; J Hatina; R Engers; A Wlazlinski; M Müller; W A Schulz
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

Review 9.  A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.